Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0027819 (
neuroblastoma
)
27,800
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
We have characterized a new member of the mammalian PAK family of serine/threonine kinases,
PAK5
, which is a novel target of the Rho GTPases Cdc42 and Rac. The kinase domain and GTPase-binding domain (GBD) of
PAK5
are most closely related in sequence to those of mammalian PAK4. Outside of these domains, however,
PAK5
is completely different in sequence from any known mammalian proteins.
PAK5
does share considerable sequence homology with the Drosophila MBT protein (for "mushroom body tiny"), however, which is thought to play a role in development of cells in Drosophila brain. Interestingly,
PAK5
is highly expressed in mammalian brain and is not expressed in most other tissues. We have found that
PAK5
, like Cdc42, promotes the induction of filopodia. In N1E-115
neuroblastoma
cells, expression of
PAK5
also triggered the induction of neurite-like processes, and a dominant-negative
PAK5
mutant inhibited neurite outgrowth. Expression of activated PAK1 caused no noticeable changes in these cells. An activated mutant of
PAK5
had an even more dramatic effect than wild-type
PAK5
, indicating that the morphologic changes induced by
PAK5
are directly related to its kinase activity. Although
PAK5
activates the JNK pathway, dominant-negative JNK did not inhibit neurite outgrowth. In contrast, the induction of neurites by
PAK5
was abolished by expression of activated RhoA. Previous work has shown that Cdc42 and Rac promote neurite outgrowth by a pathway that is antagonistic to Rho. Our results suggest, therefore, that
PAK5
operates downstream to Cdc42 and Rac and antagonizes Rho in the pathway, leading to neurite development.
...
PMID:PAK5, a new brain-specific kinase, promotes neurite outgrowth in N1E-115 cells. 1175 52
The Rho family of small GTPases controls a wide range of cellular processes in eukaryotic cells, such as normal cell growth, proliferation, differentiation, gene regulation, actin cytoskeletal organization, cell fate determination, and neurite outgrowth. The activation of Rho-GTPases requires the exchange of GDP for GTP, a process catalyzed by the Dbl family of guanine nucleotide exchange factors. We demonstrate that a newly identified guanine nucleotide exchange factor, GEFT, is widely expressed in the brain and highly concentrated in the hippocampus, and the Purkinje and granular cells of the cerebellum. Exogenous expression of GEFT promotes dendrite outgrowth in hippocampal neurons, resulting in spines with larger size as compared with control spines. In
neuroblastoma
cells, GEFT promotes the active GTP-bound state of Rac1, Cdc42, and RhoA and increases neurite outgrowth primarily via Rac1. Furthermore, we demonstrated that PAK1 and
PAK5
, both downstream effectors of Rac1/Cdc42, are necessary for GEFT-induced neurite outgrowth. AP-1 and NF-kappaB, two transcriptional factors involved in neurite outgrowth and survival, were up-regulated in GEFT-expressing cells. Together, our data suggest that GEFT enhances dendritic spine formation and neurite outgrowth in primary neurons and
neuroblastoma
cells, respectively, through the activation of Rac/Cdc42-PAK signaling pathways.
...
PMID:GEFT, a Rho family guanine nucleotide exchange factor, regulates neurite outgrowth and dendritic spine formation. 1532 8